Evidence map›Paper›PMID 18367447›Full record

ArticleThe Journal of biological chemistry2008

SLC41A1 is a novel mammalian Mg2+ carrier.

Martin Kolisek, Pierre Launay, Andreas Beck, Gerhard Sponder, Nicolas Serafini, Marcel Brenkus, Elisabeth Maria Froschauer, Holger Martens, Andrea Fleig, Monika Schweigel

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. IL-6 Does Not Influence the Expression ofInternational journal of molecular sciences · 2024
    Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Magnesium homeostasis in deoxygenated sickle erythrocytes is modulated by endothelin-1 via NaFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  12. Review
  13. Article
  14. Transcriptional Control ofInternational journal of molecular sciences · 2022
    Article
  15. Article
  16. Alzheimer's Disease-Associated SNP rs708727 inInternational journal of molecular sciences · 2022
    Article
  17. Dysregulated Erythroid MgFrontiers in cell and developmental biology · 2022
    Article
  18. Diseases caused by mutations in the NaAmerican journal of physiology. Cell physiology · 2021
    Review
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Martin KolisekInstitute of Veterinary-Physiology, FU Berlin, Oertzenweg 19b, D-14163 Berlin, Germany. martink@zedat.fu-berlin.de
Pierre Launay
Andreas Beck
Gerhard Sponder
Nicolas Serafini
Marcel Brenkus
Elisabeth Maria Froschauer
Holger Martens
Andrea Fleig
Monika Schweigel
Freie Universität Berlin · DEInserm · FRQueen's Medical Center · USMax Perutz Labs · ATResearch Institute for Farm Animal Biology (FBN) · DEUniversity of Vienna · AT

Funding

Regulation of Metal Ion Homeostasis by Channel KinasesP01GM078195 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI STOKES, JOHN B · 2007 to 2011
$8.7M
NIGMS NIH HHS P01 GM078195NIGMS NIH HHS P01GM078195
6 · The paper itself

Abstract

The molecular biology of mammalian magnesium transporters and their interrelations in cellular magnesium homeostasis are largely unknown. Recently, the mouse SLC41A1 protein was suggested to be a candidate magnesium transporter with channel-like properties when overexpressed in Xenopus laevis oocytes. Here, we demonstrate that human SLC41A1 overexpressed in HEK293 cells forms protein complexes and locates to the plasma membrane without, however, giving rise to any detectable magnesium currents during whole cell patch clamp experiments. Nevertheless, in a strain of Salmonella enterica exhibiting disruption of all three distinct magnesium transport systems (CorA, MgtA, and MgtB), overexpression of human SLC41A1 functionally substitutes these transporters and restores the growth of the mutant bacteria at magnesium concentrations otherwise non-permissive for growth. Thus, we have identified human SLC41A1 as being a bona fide magnesium transporter. Most importantly, overexpressed SLC41A1 provide HEK293 cells with an increased magnesium efflux capacity. With outwardly directed Mg(2+) gradients, a SLC41A1-dependent reduction of the free intracellular magnesium concentration accompanied by a significant net decrease of the total cellular magnesium concentration could be observed in such cells. SLC41A1 activity is temperature-sensitive but not sensitive to the only known magnesium channel blocker, cobalt(III) hexaammine. Taken together, these data functionally identify SLC41A1 as a mammalian carrier mediating magnesium efflux.

Indexed as

AnimalsAntineoplastic AgentsBacterial ProteinsCation Transport ProteinsCell LineCobaltGenetic Complementation TestHumansIon TransportMagnesiumMiceSalmonella entericaXenopus laevisAntineoplastic AgentsBacterial ProteinsCation Transport ProteinsCobalthexaamminecobalt(II)MagnesiumSLC41A1 protein, humanSlc41a2 protein, mouse

Identifiers

PMID18367447
PMCPMC2414286
OpenAlexW2023410200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.